NONALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NONALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can vitamin e tame fatty liver? new study tests best dose
Disease control CompletedThis study looked at whether vitamin E can help adults with nonalcoholic fatty liver disease (NAFLD). Researchers tested different doses of vitamin E in 200 people to see which dose best lowers liver enzymes. The goal is to find a safe and effective dose to control the disease.
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
New drug shows promise in reversing fatty liver damage
Disease control CompletedThis study tested a new medicine called efinopegdutide in 381 adults with non-alcoholic steatohepatitis (NASH), a serious liver condition. The main goal was to see if the drug could stop signs of NASH without making liver scarring worse. Researchers also checked for side effects …
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 20, 2026 11:53 UTC